TY - JOUR
T1 - Effect on carotid atherosclerosis of probucol plus levofloxacin for Chlamydia pneumoniae infection
AU - Sawayama, Yasunori
AU - Tatsukawa, Masafumi
AU - Kikuchi, Kensuke
AU - Maeda, Shinji
AU - Ohnishi, Hachiro
AU - Furusyo, Norihiro
AU - Hayashi, Jun
PY - 2007/4
Y1 - 2007/4
N2 - To investigate the effect of levofloxacin on carotid atherosclerosis, patients with hypercholesterolemia whose carotid atherosclerosis was not improved by probucol therapy (500 mg/day) for 24 months were enrolled. All patients were seropositive for anti C. pneumoniae IgA and/or IgG. Carotid atherosclerosis was evaluated by ultrasonic measurement of the maximum intima-media thickness (Max-IMT). All subjects were prescribed three courses of levofloxacin (each course, 400 mg/day for 2 weeks, followed by 14 days off drug treatment). At 12 months after combined therapy with probucol and levofloxacin, Max-IMT was significantly decreased compared with the value before treatment (P < 0.01). These results suggest that the combination therapy was effective for improving carotid atherosclerosis in C. pneumoniae-seropositive patients.
AB - To investigate the effect of levofloxacin on carotid atherosclerosis, patients with hypercholesterolemia whose carotid atherosclerosis was not improved by probucol therapy (500 mg/day) for 24 months were enrolled. All patients were seropositive for anti C. pneumoniae IgA and/or IgG. Carotid atherosclerosis was evaluated by ultrasonic measurement of the maximum intima-media thickness (Max-IMT). All subjects were prescribed three courses of levofloxacin (each course, 400 mg/day for 2 weeks, followed by 14 days off drug treatment). At 12 months after combined therapy with probucol and levofloxacin, Max-IMT was significantly decreased compared with the value before treatment (P < 0.01). These results suggest that the combination therapy was effective for improving carotid atherosclerosis in C. pneumoniae-seropositive patients.
UR - http://www.scopus.com/inward/record.url?scp=34247609358&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=34247609358&partnerID=8YFLogxK
U2 - 10.1007/s10156-007-0510-2
DO - 10.1007/s10156-007-0510-2
M3 - Article
C2 - 17458676
AN - SCOPUS:34247609358
SN - 1341-321X
VL - 13
SP - 92
EP - 98
JO - Journal of Infection and Chemotherapy
JF - Journal of Infection and Chemotherapy
IS - 2
ER -